vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and MACOM Technology Solutions Holdings, Inc. (MTSI). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $271.6M, roughly 1.8× MACOM Technology Solutions Holdings, Inc.). MACOM Technology Solutions Holdings, Inc. runs the higher net margin — 18.0% vs -10.1%, a 28.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 24.5%). MACOM Technology Solutions Holdings, Inc. produced more free cash flow last quarter ($30.0M vs $-69.0M). Over the past eight quarters, MACOM Technology Solutions Holdings, Inc.'s revenue compounded faster (22.4% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

MACOM Technology Solutions, Inc. is an American developer and producer of radio, microwave, and millimeter wave semiconductor devices and components. The company is headquartered in Lowell, Massachusetts, and in 2005 was Lowell's largest private employer. MACOM is certified to the ISO 9001 international quality standard and ISO 14001 environmental standard. The company has design centers and sales offices in North America, Europe, Asia and Australia.

CLOV vs MTSI — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.8× larger
CLOV
$487.7M
$271.6M
MTSI
Growing faster (revenue YoY)
CLOV
CLOV
+20.2% gap
CLOV
44.7%
24.5%
MTSI
Higher net margin
MTSI
MTSI
28.1% more per $
MTSI
18.0%
-10.1%
CLOV
More free cash flow
MTSI
MTSI
$99.0M more FCF
MTSI
$30.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
MTSI
MTSI
Annualised
MTSI
22.4%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
MTSI
MTSI
Revenue
$487.7M
$271.6M
Net Profit
$-49.3M
$48.8M
Gross Margin
55.9%
Operating Margin
-10.1%
15.9%
Net Margin
-10.1%
18.0%
Revenue YoY
44.7%
24.5%
Net Profit YoY
-123.2%
129.1%
EPS (diluted)
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MTSI
MTSI
Q1 26
$271.6M
Q4 25
$487.7M
$261.2M
Q3 25
$496.6M
$252.1M
Q2 25
$477.6M
$235.9M
Q1 25
$462.3M
$218.1M
Q4 24
$337.0M
Q3 24
$331.0M
$200.7M
Q2 24
$356.3M
$190.5M
Net Profit
CLOV
CLOV
MTSI
MTSI
Q1 26
$48.8M
Q4 25
$-49.3M
$45.1M
Q3 25
$-24.4M
$36.5M
Q2 25
$-10.6M
$31.7M
Q1 25
$-1.3M
$-167.5M
Q4 24
$-22.1M
Q3 24
$-9.2M
$29.4M
Q2 24
$7.4M
$19.9M
Gross Margin
CLOV
CLOV
MTSI
MTSI
Q1 26
55.9%
Q4 25
54.5%
Q3 25
55.3%
Q2 25
55.2%
Q1 25
53.7%
Q4 24
Q3 24
24.5%
54.7%
Q2 24
30.3%
53.2%
Operating Margin
CLOV
CLOV
MTSI
MTSI
Q1 26
15.9%
Q4 25
-10.1%
15.2%
Q3 25
-4.9%
14.9%
Q2 25
-2.2%
14.8%
Q1 25
-0.3%
8.0%
Q4 24
-6.4%
Q3 24
-2.7%
13.7%
Q2 24
2.0%
10.4%
Net Margin
CLOV
CLOV
MTSI
MTSI
Q1 26
18.0%
Q4 25
-10.1%
17.3%
Q3 25
-4.9%
14.5%
Q2 25
-2.2%
13.4%
Q1 25
-0.3%
-76.8%
Q4 24
-6.6%
Q3 24
-2.8%
14.7%
Q2 24
2.1%
10.5%
EPS (diluted)
CLOV
CLOV
MTSI
MTSI
Q1 26
$0.64
Q4 25
$0.67
Q3 25
$0.48
Q2 25
$0.42
Q1 25
$-2.30
Q4 24
Q3 24
$0.40
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MTSI
MTSI
Cash + ST InvestmentsLiquidity on hand
$78.3M
$768.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.4B
Total Assets
$541.0M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MTSI
MTSI
Q1 26
$768.5M
Q4 25
$78.3M
$786.0M
Q3 25
$735.2M
Q2 25
$681.5M
Q1 25
$656.5M
Q4 24
$194.5M
Q3 24
$288.0M
$581.9M
Q2 24
$254.8M
$521.5M
Stockholders' Equity
CLOV
CLOV
MTSI
MTSI
Q1 26
$1.4B
Q4 25
$308.7M
$1.3B
Q3 25
$340.9M
$1.3B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.2B
Q4 24
$341.1M
Q3 24
$342.2M
$1.1B
Q2 24
$324.9M
$1.1B
Total Assets
CLOV
CLOV
MTSI
MTSI
Q1 26
$2.1B
Q4 25
$541.0M
$2.1B
Q3 25
$559.7M
$2.0B
Q2 25
$575.0M
$1.9B
Q1 25
$583.7M
$1.8B
Q4 24
$580.7M
Q3 24
$653.0M
$1.8B
Q2 24
$674.2M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MTSI
MTSI
Operating Cash FlowLast quarter
$-66.9M
$42.9M
Free Cash FlowOCF − Capex
$-69.0M
$30.0M
FCF MarginFCF / Revenue
-14.1%
11.0%
Capex IntensityCapex / Revenue
0.4%
4.8%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$161.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MTSI
MTSI
Q1 26
$42.9M
Q4 25
$-66.9M
$69.6M
Q3 25
$12.1M
$60.4M
Q2 25
$5.4M
$38.7M
Q1 25
$-16.3M
$66.7M
Q4 24
$34.8M
Q3 24
$50.0M
$62.3M
Q2 24
$44.8M
$49.0M
Free Cash Flow
CLOV
CLOV
MTSI
MTSI
Q1 26
$30.0M
Q4 25
$-69.0M
$49.4M
Q3 25
$11.4M
$51.6M
Q2 25
$4.8M
$30.5M
Q1 25
$-16.5M
$61.3M
Q4 24
$33.3M
Q3 24
$49.6M
$57.1M
Q2 24
$44.4M
$41.5M
FCF Margin
CLOV
CLOV
MTSI
MTSI
Q1 26
11.0%
Q4 25
-14.1%
18.9%
Q3 25
2.3%
20.5%
Q2 25
1.0%
12.9%
Q1 25
-3.6%
28.1%
Q4 24
9.9%
Q3 24
15.0%
28.5%
Q2 24
12.5%
21.8%
Capex Intensity
CLOV
CLOV
MTSI
MTSI
Q1 26
4.8%
Q4 25
0.4%
7.7%
Q3 25
0.1%
3.5%
Q2 25
0.1%
3.5%
Q1 25
0.0%
2.4%
Q4 24
0.5%
Q3 24
0.1%
2.6%
Q2 24
0.1%
3.9%
Cash Conversion
CLOV
CLOV
MTSI
MTSI
Q1 26
0.88×
Q4 25
1.54×
Q3 25
1.65×
Q2 25
1.22×
Q1 25
Q4 24
Q3 24
2.12×
Q2 24
6.04×
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MTSI
MTSI

Industrial Defense$117.7M43%
Data Center$85.8M32%
Telecom$68.1M25%

Related Comparisons